Impaired 24-h activity patterns are associated with an increased risk of Alzheimer's disease, Parkinson's disease, and cognitive decline.
Alzheimer’s disease
Cognitive aging
Parkinson’s disease
Rest-activity rhythms
Journal
Alzheimer's research & therapy
ISSN: 1758-9193
Titre abrégé: Alzheimers Res Ther
Pays: England
ID NLM: 101511643
Informations de publication
Date de publication:
14 Feb 2024
14 Feb 2024
Historique:
received:
12
09
2023
accepted:
05
02
2024
medline:
15
2
2024
pubmed:
15
2
2024
entrez:
14
2
2024
Statut:
epublish
Résumé
Sleep-wake regulating circuits are affected during prodromal stages in the pathological progression of both Alzheimer's disease (AD) and Parkinson's disease (PD), and this disturbance can be measured passively using wearable devices. Our objective was to determine whether accelerometer-based measures of 24-h activity are associated with subsequent development of AD, PD, and cognitive decline. This study obtained UK Biobank data from 82,829 individuals with wrist-worn accelerometer data aged 40 to 79 years with a mean (± SD) follow-up of 6.8 (± 0.9) years. Outcomes were accelerometer-derived measures of 24-h activity (derived by cosinor, nonparametric, and functional principal component methods), incident AD and PD diagnosis (obtained through hospitalization or primary care records), and prospective longitudinal cognitive testing. One hundred eighty-seven individuals progressed to AD and 265 to PD. Interdaily stability (a measure of regularity, hazard ratio [HR] per SD increase 1.25, 95% confidence interval [CI] 1.05-1.48), diurnal amplitude (HR 0.79, CI 0.65-0.96), mesor (mean activity; HR 0.77, CI 0.59-0.998), and activity during most active 10 h (HR 0.75, CI 0.61-0.94), were associated with risk of AD. Diurnal amplitude (HR 0.28, CI 0.23-0.34), mesor (HR 0.13, CI 0.10-0.16), activity during least active 5 h (HR 0.24, CI 0.08-0.69), and activity during most active 10 h (HR 0.20, CI 0.16-0.25) were associated with risk of PD. Several measures were additionally predictive of longitudinal cognitive test performance. In this community-based longitudinal study, accelerometer-derived metrics were associated with elevated risk of AD, PD, and accelerated cognitive decline. These findings suggest 24-h rhythm integrity, as measured by affordable, non-invasive wearable devices, may serve as a scalable early marker of neurodegenerative disease.
Sections du résumé
BACKGROUND
BACKGROUND
Sleep-wake regulating circuits are affected during prodromal stages in the pathological progression of both Alzheimer's disease (AD) and Parkinson's disease (PD), and this disturbance can be measured passively using wearable devices. Our objective was to determine whether accelerometer-based measures of 24-h activity are associated with subsequent development of AD, PD, and cognitive decline.
METHODS
METHODS
This study obtained UK Biobank data from 82,829 individuals with wrist-worn accelerometer data aged 40 to 79 years with a mean (± SD) follow-up of 6.8 (± 0.9) years. Outcomes were accelerometer-derived measures of 24-h activity (derived by cosinor, nonparametric, and functional principal component methods), incident AD and PD diagnosis (obtained through hospitalization or primary care records), and prospective longitudinal cognitive testing.
RESULTS
RESULTS
One hundred eighty-seven individuals progressed to AD and 265 to PD. Interdaily stability (a measure of regularity, hazard ratio [HR] per SD increase 1.25, 95% confidence interval [CI] 1.05-1.48), diurnal amplitude (HR 0.79, CI 0.65-0.96), mesor (mean activity; HR 0.77, CI 0.59-0.998), and activity during most active 10 h (HR 0.75, CI 0.61-0.94), were associated with risk of AD. Diurnal amplitude (HR 0.28, CI 0.23-0.34), mesor (HR 0.13, CI 0.10-0.16), activity during least active 5 h (HR 0.24, CI 0.08-0.69), and activity during most active 10 h (HR 0.20, CI 0.16-0.25) were associated with risk of PD. Several measures were additionally predictive of longitudinal cognitive test performance.
CONCLUSIONS
CONCLUSIONS
In this community-based longitudinal study, accelerometer-derived metrics were associated with elevated risk of AD, PD, and accelerated cognitive decline. These findings suggest 24-h rhythm integrity, as measured by affordable, non-invasive wearable devices, may serve as a scalable early marker of neurodegenerative disease.
Identifiants
pubmed: 38355598
doi: 10.1186/s13195-024-01411-0
pii: 10.1186/s13195-024-01411-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
35Informations de copyright
© 2024. The Author(s).
Références
Hou Y, Dan X, Babbar M, et al. Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol. Nature Publishing Group; 2019;15:565–581.
Poewe W, Seppi K, Tanner CM, et al. Parkinson disease. Nat Rev Dis Primers. Nature Publishing Group; 2017;3:1–21.
Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging. 1997;18:351–7.
pubmed: 9330961
doi: 10.1016/S0197-4580(97)00056-0
Braak H, Tredici KD, Rüb U, de Vos RAI, Jansen Steur ENH, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging. 2003;24:197–211.
pubmed: 12498954
doi: 10.1016/S0197-4580(02)00065-9
Lim ASP, Ellison BA, Wang JL, et al. Sleep is related to neuron numbers in the ventrolateral preoptic/intermediate nucleus in older adults with and without Alzheimer’s disease. Brain. 2014;137:2847–61.
pubmed: 25142380
pmcid: 4163039
doi: 10.1093/brain/awu222
Musiek ES, Bhimasani M, Zangrilli MA, Morris JC, Holtzman DM, Ju Y-ES. Circadian rest-activity pattern changes in aging and preclinical Alzheimer disease. JAMA Neurol. 2018;75:582–90.
pubmed: 29379963
doi: 10.1001/jamaneurol.2017.4719
Stern AL, Naidoo N. Wake-active neurons across aging and neurodegeneration: a potential role for sleep disturbances in promoting disease. Springerplus. 2015;4:25.
pubmed: 25635245
pmcid: 4306674
doi: 10.1186/s40064-014-0777-6
Buchman AS, Boyle PA, Yu L, Shah RC, Wilson RS, Bennett DA. Total daily physical activity and the risk of AD and cognitive decline in older adults. Neurology AAN Enterprises. 2012;78:1323–9.
Lim ASP, Kowgier M, Yu L, Buchman AS, Bennett DA. sleep fragmentation and the risk of incident Alzheimer’s disease and cognitive decline in older persons. Sleep. 2013;36:1027–32.
pubmed: 23814339
pmcid: 3669060
doi: 10.5665/sleep.2802
Walsh CM, Blackwell T, Tranah GJ, et al. Weaker circadian activity rhythms are associated with poorer executive function in older women. Sleep Oxford Academ. 2014;37:2009–16.
doi: 10.5665/sleep.4260
Xiao Q, Sampson JN, LaCroix AZ, et al. Nonparametric parameters of 24-hour rest-activity rhythms and long-term cognitive decline and incident cognitive impairment in older men. J Gerontol A Biol Sci Med Sci. 2022;77:250–8.
pubmed: 34558603
doi: 10.1093/gerona/glab275
Rogers-Soeder TS, Blackwell T, Yaffe K, et al. Rest-activity rhythms and cognitive decline in older men: the osteoporotic fractures in men sleep study. J Am Geriatr Soc. 2018;66:2136–43.
pubmed: 30136716
pmcid: 6235690
doi: 10.1111/jgs.15555
Tranah GJ, Blackwell T, Stone KL, et al. Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women. Ann Neurol. 2011;70:722–32.
pubmed: 22162057
pmcid: 3244839
doi: 10.1002/ana.22468
Li P, Gao L, Gaba A, et al. Circadian disturbances in Alzheimer’s disease progression: a prospective observational cohort study of community-based older adults. Lancet Healthy Longev. 2020;1:e96–e105.
pubmed: 34179863
pmcid: 8232345
doi: 10.1016/S2666-7568(20)30015-5
Leng Y, Blackwell T, Cawthon PM, Ancoli-Israel S, Stone KL, Yaffe K. Association of circadian abnormalities in older adults with an increased risk of developing parkinson disease. JAMA Neurol. Epub 2020 Jun 15.
Lysen TS, Luik AI, Ikram MK, Tiemeier H, Ikram MA. Actigraphy-estimated sleep and 24-hour activity rhythms and the risk of dementia. Alzheimers Dement. 2020;16:1259–67.
pubmed: 32558256
pmcid: 7984295
doi: 10.1002/alz.12122
Doherty A, Jackson D, Hammerla N, et al. Large scale population assessment of physical activity using wrist worn accelerometers: the UK Biobank study, vol. 12. PLOS ONE Public Library of Science; 2017. p. e0169649.
Weed L, Lok R, Chawra D, Zeitzer J. The impact of missing data and imputation methods on the analysis of 24-hour activity patterns. Clocks Sleep. 2022;4:497–507.
pubmed: 36278532
pmcid: 9590093
doi: 10.3390/clockssleep4040039
Cornelissen G. Cosinor-based rhythmometry. Theor Biol Med Model. 2014;11:16.
pubmed: 24725531
pmcid: 3991883
doi: 10.1186/1742-4682-11-16
Blume C, Santhi N, Schabus M. “nparACT” package for R: a free software tool for the non-parametric analysis of actigraphy data. MethodsX. 2016;3:430–435.
Van Someren EJ, Swaab DF, Colenda CC, Cohen W, McCall WV, Rosenquist PB. Bright light therapy: improved sensitivity to its effects on rest-activity rhythms in Alzheimer patients by application of nonparametric methods. Chronobiol Int. 1999;16:505–18.
pubmed: 10442243
doi: 10.3109/07420529908998724
Ding J, Symanzik J, Sharif A, Wang J, Duntley S, Shannon WD. Powerful actigraphy data through functional representation. CHANCE. Taylor & Francis; 2011;24:30–36.
Zeitzer JM, David R, Friedman L, et al. Phenotyping apathy in individuals with Alzheimer disease using functional principal component analysis. Am J Geriat Psychiatry Elsevier. 2013;21:391–7.
doi: 10.1016/j.jagp.2012.12.012
Zeitzer JM, Blackwell T, Hoffman AR, et al. Daily patterns of accelerometer activity predict changes in sleep, cognition, and mortality in older men. The Journals of Gerontology: Series A. Oxford University Press US. 2018;73:682–7.
Ho DE, Imai K, King G, Stuart EA. Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference. Political Analysis Cambridge University Press. 2007;15:199–236.
doi: 10.1093/pan/mpl013
Wilkinson T, Ly A, Schnier C, et al. Identifying dementia cases with routinely collected health data: a systematic review. Alzheimers Dement. 2018;14:1038–51.
pubmed: 29621480
pmcid: 6105076
doi: 10.1016/j.jalz.2018.02.016
Wilkinson T, Schnier C, Bush K, et al. Identifying dementia outcomes in UK Biobank: a validation study of primary care, hospital admissions and mortality data. Eur J Epidemiol. 2019;34:557–65.
pubmed: 30806901
pmcid: 6497624
doi: 10.1007/s10654-019-00499-1
Blauwendraat C, Iwaki H, Makarious MB, et al. Investigation of autosomal genetic sex differences in Parkinson’s disease. Ann Neurol. 2021;90:35–42.
pubmed: 33901317
pmcid: 8422907
doi: 10.1002/ana.26090
Lyall DM, Cullen B, Allerhand M, et al. Cognitive test scores in UK Biobank: data reduction in 480,416 participants and longitudinal stability in 20,346 participants. PLoS One. 2016;11:e0154222.
pubmed: 27110937
pmcid: 4844168
doi: 10.1371/journal.pone.0154222
Honaker J, King G, Blackwell M. Amelia II: a program for missing data. J Statist Softw. 2011;45:1–47.
doi: 10.18637/jss.v045.i07
Schalkamp A-K, Peall KJ, Harrison NA, Sandor C. Wearable movement-tracking data identify Parkinson’s disease years before clinical diagnosis. Nat Med. 2023;29:2048–56.
pubmed: 37400639
doi: 10.1038/s41591-023-02440-2
Leng Y, Musiek ES, Hu K, Cappuccio FP, Yaffe K. Association between circadian rhythms and neurodegenerative diseases. Lancet Neurol. 2019;18:307–18.
pubmed: 30784558
pmcid: 6426656
doi: 10.1016/S1474-4422(18)30461-7
Al-Qassabi A, Fereshtehnejad S-M, Postuma RB. Sleep disturbances in the prodromal stage of Parkinson disease. Curr Treat Options Neurol. 2017;19:22.
pubmed: 28466429
doi: 10.1007/s11940-017-0458-1
Gao J, Huang X, Park Y, et al. Daytime napping, nighttime sleeping, and Parkinson disease. Am J Epidemiol. 2011;173:1032–8.
pubmed: 21402730
pmcid: 3121222
doi: 10.1093/aje/kwq478
Abbott RD, Ross GW, White LR, et al. Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurol. 2005;65:1442–6.
doi: 10.1212/01.wnl.0000183056.89590.0d
Leng Y, Goldman SM, Cawthon PM, Stone KL, Ancoli-Israel S, Yaffe K. Excessive daytime sleepiness, objective napping and 11-year risk of Parkinson’s disease in older men. Int J Epidemiol. 2018;47:1679–86.
pubmed: 29873737
pmcid: 6208269
doi: 10.1093/ije/dyy098
Ferreira-Sánchez MD, Moreno-Verdú M, Cano-de-La-Cuerda R. Quantitative measurement of rigidity in Parkinson’s disease: a systematic review. Sensors Multidiscip Digit Publish Institute. 2020;20:880.
Högl B, Stefani A, Videnovic A. Idiopathic REM sleep behaviour disorder and neurodegeneration - an update. Nat Rev Neurol. 2018;14:40–55.
pubmed: 29170501
doi: 10.1038/nrneurol.2017.157
Filardi M, Stefani A, Holzknecht E, Pizza F, Plazzi G, Högl B. Objective rest-activity cycle analysis by actigraphy identifies isolated rapid eye movement sleep behavior disorder. Eur J Neurol. 2020;27:1848–55.
pubmed: 32515101
doi: 10.1111/ene.14386
Brink-Kjaer A, Gupta N, Marin E, et al. Ambulatory detection of isolated rapid-eye-movement sleep behavior disorder combining actigraphy and questionnaire. Mov Disord. 2023;38:82–91.
pubmed: 36258659
doi: 10.1002/mds.29249
Chahine LM, Amara AW, Videnovic A. A systematic review of the literature on disorders of sleep and wakefulness in Parkinson’s disease from 2005 to 2015. Sleep Med Rev. 2017;35:33–50.
pubmed: 27863901
doi: 10.1016/j.smrv.2016.08.001
Smith A. Symbol Digit Modalities Test: Manual. Los Angeles: Western Psychological Services; 1982.
Reitan RM, Wolfson D. The Halstead-Reitan neuropsychological test battery: theory and clinical interpretation. Tucson: Neuropsychological Press; 1985.
Rabin JS, Klein H, Kirn DR, et al. Associations of physical activity and β-amyloid with longitudinal cognition and neurodegeneration in clinically normal older adults. JAMA Neurol. 2019;76:1203–10.
pubmed: 31312836
pmcid: 6635892
doi: 10.1001/jamaneurol.2019.1879
Musiek ES, Xiong DD, Holtzman DM. Sleep, circadian rhythms, and the pathogenesis of Alzheimer disease. Experiment Molecular Med. 2015;47:e148.
doi: 10.1038/emm.2014.121
Kanady JC, Drummond SPA, Mednick SC. Actigraphic assessment of a polysomnographic-recorded nap: a validation study. J Sleep Res. 2011;20:214–22.
pubmed: 20626612
doi: 10.1111/j.1365-2869.2010.00858.x
Matthews FE, Chatfield M, Freeman C, McCracken C, Brayne C, CFAS M. Attrition and bias in the MRC cognitive function and ageing study: an epidemiological investigation. BMC Public Health. 2004;4:12.
pubmed: 15113437
pmcid: 419705
doi: 10.1186/1471-2458-4-12